SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-062787
Filing Date
2017-12-07
Accepted
2017-12-07 16:16:01
Documents
3
Period of Report
2017-12-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv480927_8k.htm 8-K 23369
2 EXHIBIT 99.1 tv480927_ex99-1.htm EX-99.1 193945
3 GRAPHIC logo.jpg GRAPHIC 9048
  Complete submission text file 0001144204-17-062787.txt   231215
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 171244928
SIC: 2834 Pharmaceutical Preparations